21 programs · audited weekly · read The Audit →

GLP-1 weight-loss medications · US

The price in the ad is not the price you pay.

We audit 21 GLP-1 programs every week — manufacturer-direct, telehealth, retail, and discount cards — and publish the real monthly cost at the dose you'll actually take. No vendor pays us. Every number has a source and a date.

1.75×median gap between advertised and real maintenance-dose price (n=11, our audit)
$1,319a "discounted" Wegovy month with a GoodRx coupon — 3.8× the manufacturer's own cash price
$349real flat price of Wegovy pen, all standard doses, direct from NovoCare
$50flat Medicare Bridge copay at any pharmacy — if you qualify, nothing beats it

Real prices, maintenance dose, this week

Advertised price is what the banner says. Real price is the all-in monthly cost at a typical maintenance dose after intro offers expire — membership fees included. Struck-through numbers are the teasers.

ProgramWhat it isAdvertisedReal / monthGapWatch out

Core rows re-verified Sep 6–21, 2026 in The Audit; remaining rows as of 2026-08-16. "Real" = maintenance dose, post-intro, membership included. This is pricing information, not medical advice.

The four traps we keep finding

Patterns from this week's audit that cost real people real money.

3.8×

The GoodRx trap

Coupons barely touch Wegovy and Zepbound — around 5–10% off a $1,300+ sticker. Buying direct from the manufacturer is $349–449. The "discount card" route costs up to 3.8× more.

+$150–600

The 45-day rule

LillyDirect's $449 maintenance price only holds if you refill within 45 days. Miss the window once and the same box runs $599 to $1,049 a month depending on dose.

$597

The 12-week lump

Noom Med advertises per-month tiers but bills in 12-week lumps: the "$199/mo" plan actually charges about $597 per quarter to your card.

$39 → $454

The membership teaser

"$39 first month" usually buys the membership, not the medicine. All-in cost at Hims, Ro, or LifeMD lands between $300 and $450 once the drug is added.

How this audit works

  • No vendor pays for placement. If we ever add referral links, they'll be labeled on the exact line they appear — never mixed into rankings.
  • Every number carries a source and a date. Official program pages first; where a company blocks verification, the row says so.
  • Prices re-checked every Monday. Intro offers in this market expire on hard dates (two big ones die Aug 31, 2026) — stale numbers are wrong numbers.
  • Corrections are public. Wrong number? Tell us, we fix it and log the fix.

Get your Access Report

Tell us your medication, insurance situation, and zip — we'll map your cheapest legitimate paths, the traps to avoid, and alert you when a price on your list drops or an intro offer is about to expire.

One email a week. Unsubscribe in one click.

Questions people actually ask

Why is my price different from the advertised one?

Advertised prices are almost always the starter dose, the first month, or the longest prepay bundle. At a typical maintenance dose, month to month, our audit measures a median 1.75× gap between the banner and the bill.

Is GoodRx ever worth it for Wegovy or Zepbound?

For these two brand-name drugs, rarely. Manufacturer contracts block deep coupon discounts, so the "discounted" price stays near sticker ($1,000–1,400/mo). LillyDirect and NovoCare sell the same drugs direct for $349–449.

What's the risk with compounded programs?

They're often cheaper, but they sell versions of the drug that are not FDA-approved, and the FDA moved against large-scale GLP-1 compounding in 2026. Several programs have already shut down or pivoted — a price that depends on one is a price that can vanish. We flag every compounded row.

Who pays for this site?

Today: nobody — it's independent. If that changes, every paid relationship will be disclosed on the line where it exists. Rankings are never for sale.

DoseTruth is pricing information, not medical advice. Talk to your clinician about what's right for you. Prices are estimates based on published program information as of the date shown and can change without notice. Insurance figures are estimates, not guarantees of coverage.

All product and company names are trademarks of their respective holders; their use here is for identification and comparison only. © 2026 DoseTruth · operated by KY Solutions.

From the audit

Latest findings from the weekly rebuild.

All audit notes →